IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $537,332 | +308.5% | 193,285 | +167.5% | 0.00% | – |
Q1 2023 | $131,524 | -97.1% | 72,266 | -91.9% | 0.00% | -100.0% |
Q4 2022 | $4,547,593 | +1810.8% | 896,961 | +1772.3% | 0.01% | +1100.0% |
Q3 2022 | $238,000 | -1.7% | 47,907 | -26.2% | 0.00% | 0.0% |
Q2 2022 | $242,000 | – | 64,945 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $4,180,000 | 0.56% |
HARBOURVEST PARTNERS LLC | 335,709 | $2,041,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $586,000 | 0.20% |
SHEETS SMITH WEALTH MANAGEMENT | 152,276 | $926,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 129,260 | $786,000 | 0.10% |
Clearwater Capital Advisors, LLC | 140,551 | $855,000 | 0.09% |
Virtus ETF Advisers LLC | 28,969 | $176,000 | 0.07% |
XTX Topco Ltd | 19,159 | $116,000 | 0.07% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 49,464 | $301,000 | 0.04% |
Vident Investment Advisory, LLC | 168,476 | $1,024,000 | 0.03% |